| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pseudomonas aeruginosa | 36 | 2021 | 194 | 4.370 |
Why?
|
| Anastomotic Leak | 17 | 2023 | 96 | 2.060 |
Why?
|
| Pseudomonas Infections | 16 | 2019 | 95 | 1.810 |
Why?
|
| Intestinal Mucosa | 21 | 2017 | 797 | 1.420 |
Why?
|
| Enterococcus faecalis | 12 | 2022 | 46 | 1.350 |
Why?
|
| Sepsis | 16 | 2020 | 306 | 1.130 |
Why?
|
| Surgical Wound Infection | 7 | 2022 | 184 | 0.990 |
Why?
|
| Phosphates | 12 | 2022 | 160 | 0.940 |
Why?
|
| Intestines | 14 | 2020 | 411 | 0.930 |
Why?
|
| Polyethylene Glycols | 10 | 2020 | 363 | 0.850 |
Why?
|
| Virulence | 23 | 2020 | 271 | 0.810 |
Why?
|
| Macrophages | 11 | 2017 | 554 | 0.780 |
Why?
|
| Bacterial Proteins | 10 | 2020 | 864 | 0.700 |
Why?
|
| Colon | 8 | 2021 | 496 | 0.690 |
Why?
|
| Collagenases | 7 | 2022 | 39 | 0.680 |
Why?
|
| Anastomosis, Surgical | 12 | 2023 | 267 | 0.670 |
Why?
|
| Diet, Western | 5 | 2023 | 37 | 0.640 |
Why?
|
| Mice | 45 | 2023 | 11352 | 0.630 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 3 | 2013 | 44 | 0.620 |
Why?
|
| Mice, Inbred C57BL | 25 | 2021 | 3092 | 0.610 |
Why?
|
| Gastrointestinal Microbiome | 8 | 2021 | 455 | 0.600 |
Why?
|
| Wound Healing | 6 | 2019 | 344 | 0.570 |
Why?
|
| Animals | 62 | 2023 | 26582 | 0.570 |
Why?
|
| Receptors, Purinergic P2 | 4 | 2000 | 15 | 0.560 |
Why?
|
| Stress, Physiological | 5 | 2011 | 227 | 0.550 |
Why?
|
| Phosphate-Binding Proteins | 2 | 2014 | 9 | 0.510 |
Why?
|
| Cell Membrane Structures | 1 | 2014 | 3 | 0.490 |
Why?
|
| Cell Surface Extensions | 1 | 2014 | 11 | 0.480 |
Why?
|
| Colectomy | 3 | 2019 | 167 | 0.470 |
Why?
|
| Microscopy, Electron | 1 | 2014 | 503 | 0.460 |
Why?
|
| Caenorhabditis elegans | 10 | 2016 | 223 | 0.450 |
Why?
|
| Gastrointestinal Tract | 5 | 2020 | 191 | 0.450 |
Why?
|
| Colorectal Surgery | 2 | 2023 | 22 | 0.430 |
Why?
|
| Disease Models, Animal | 14 | 2023 | 2232 | 0.420 |
Why?
|
| Plasminogen | 2 | 2021 | 41 | 0.380 |
Why?
|
| Adhesins, Bacterial | 6 | 2012 | 36 | 0.380 |
Why?
|
| Lectins | 6 | 2012 | 84 | 0.370 |
Why?
|
| Microbiota | 4 | 2016 | 381 | 0.370 |
Why?
|
| Gene Expression Regulation, Bacterial | 3 | 2011 | 204 | 0.350 |
Why?
|
| Adenosine Triphosphate | 6 | 2007 | 314 | 0.350 |
Why?
|
| Matrix Metalloproteinase 9 | 3 | 2020 | 78 | 0.350 |
Why?
|
| Digestive System Surgical Procedures | 3 | 2021 | 120 | 0.350 |
Why?
|
| Colorectal Neoplasms | 3 | 2023 | 938 | 0.340 |
Why?
|
| Anti-Bacterial Agents | 9 | 2022 | 746 | 0.330 |
Why?
|
| Quorum Sensing | 2 | 2013 | 26 | 0.330 |
Why?
|
| Periplasmic Binding Proteins | 1 | 2008 | 25 | 0.320 |
Why?
|
| Quinolones | 2 | 2012 | 60 | 0.320 |
Why?
|
| Hydrogels | 2 | 2020 | 82 | 0.320 |
Why?
|
| Intestinal Diseases | 3 | 2016 | 79 | 0.310 |
Why?
|
| Polyphosphates | 2 | 2018 | 7 | 0.310 |
Why?
|
| Nucleoside-Diphosphate Kinase | 4 | 2007 | 11 | 0.310 |
Why?
|
| Dynorphins | 1 | 2007 | 14 | 0.300 |
Why?
|
| Hydroquinones | 2 | 1998 | 8 | 0.300 |
Why?
|
| RNA, Ribosomal, 16S | 7 | 2021 | 241 | 0.280 |
Why?
|
| Apoptosis | 9 | 2016 | 1683 | 0.280 |
Why?
|
| Burkholderia cepacia | 3 | 2003 | 3 | 0.270 |
Why?
|
| Postoperative Complications | 5 | 2019 | 2207 | 0.270 |
Why?
|
| Pyocyanine | 4 | 2016 | 12 | 0.260 |
Why?
|
| Mice, Inbred BALB C | 10 | 2023 | 1047 | 0.260 |
Why?
|
| Analgesics, Opioid | 3 | 2016 | 413 | 0.260 |
Why?
|
| Critical Illness | 4 | 2014 | 294 | 0.250 |
Why?
|
| Bacteria | 3 | 2020 | 447 | 0.250 |
Why?
|
| Tranexamic Acid | 2 | 2021 | 25 | 0.240 |
Why?
|
| Epithelial Cells | 5 | 2017 | 669 | 0.240 |
Why?
|
| Humans | 46 | 2023 | 86617 | 0.240 |
Why?
|
| Collagen | 4 | 2021 | 269 | 0.240 |
Why?
|
| Butyrates | 2 | 2020 | 42 | 0.240 |
Why?
|
| Peptide YY | 1 | 2023 | 9 | 0.240 |
Why?
|
| Paneth Cells | 1 | 2023 | 9 | 0.240 |
Why?
|
| Candida | 1 | 2023 | 17 | 0.230 |
Why?
|
| Signal Transduction | 5 | 2020 | 3241 | 0.230 |
Why?
|
| Morphine | 2 | 2016 | 130 | 0.230 |
Why?
|
| Virulence Factors | 4 | 2017 | 108 | 0.230 |
Why?
|
| Fecal Microbiota Transplantation | 2 | 2020 | 62 | 0.220 |
Why?
|
| Bacterial Adhesion | 5 | 2013 | 84 | 0.220 |
Why?
|
| Infection Control | 2 | 2017 | 115 | 0.220 |
Why?
|
| Azurin | 4 | 2003 | 5 | 0.220 |
Why?
|
| Antifungal Agents | 1 | 2023 | 117 | 0.220 |
Why?
|
| Host-Pathogen Interactions | 3 | 2019 | 231 | 0.220 |
Why?
|
| Iron | 4 | 2017 | 164 | 0.220 |
Why?
|
| Biofilms | 4 | 2018 | 42 | 0.210 |
Why?
|
| Adenosine Triphosphatases | 3 | 2000 | 153 | 0.210 |
Why?
|
| Serratia marcescens | 2 | 2020 | 5 | 0.210 |
Why?
|
| Drinking Water | 1 | 2022 | 64 | 0.210 |
Why?
|
| Cecum | 4 | 2016 | 68 | 0.200 |
Why?
|
| Maleates | 2 | 1998 | 3 | 0.200 |
Why?
|
| Caspases | 2 | 2003 | 155 | 0.200 |
Why?
|
| Peptide Fragments | 1 | 2023 | 460 | 0.200 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2019 | 71 | 0.200 |
Why?
|
| Pancreatitis | 1 | 2021 | 87 | 0.200 |
Why?
|
| Pancreatitis, Acute Necrotizing | 1 | 2020 | 16 | 0.190 |
Why?
|
| Clonidine | 1 | 2020 | 37 | 0.190 |
Why?
|
| Propranolol | 1 | 2020 | 45 | 0.190 |
Why?
|
| Intestine, Small | 2 | 2013 | 303 | 0.190 |
Why?
|
| Caco-2 Cells | 7 | 2011 | 123 | 0.190 |
Why?
|
| Rectal Neoplasms | 1 | 2021 | 116 | 0.180 |
Why?
|
| Diet, Fat-Restricted | 1 | 2019 | 30 | 0.180 |
Why?
|
| Peptide Hydrolases | 1 | 2020 | 100 | 0.180 |
Why?
|
| Collagen Type IV | 1 | 2019 | 24 | 0.180 |
Why?
|
| Cystic Fibrosis | 2 | 2003 | 112 | 0.180 |
Why?
|
| Dietary Fiber | 1 | 2019 | 43 | 0.180 |
Why?
|
| Bacillus subtilis | 1 | 2020 | 89 | 0.180 |
Why?
|
| Preoperative Care | 2 | 2019 | 394 | 0.180 |
Why?
|
| Fibrinolysis | 1 | 2019 | 35 | 0.180 |
Why?
|
| Acinetobacter baumannii | 2 | 2017 | 26 | 0.180 |
Why?
|
| Collagen Type I | 1 | 2019 | 62 | 0.180 |
Why?
|
| Immune System | 1 | 2020 | 93 | 0.170 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2019 | 47 | 0.170 |
Why?
|
| Immunity | 1 | 2020 | 136 | 0.170 |
Why?
|
| Fimbriae Proteins | 1 | 1999 | 15 | 0.170 |
Why?
|
| Mycobacterium bovis | 1 | 1999 | 16 | 0.170 |
Why?
|
| Colonic Diseases | 1 | 2019 | 65 | 0.170 |
Why?
|
| Hepatectomy | 4 | 2018 | 166 | 0.170 |
Why?
|
| Lyases | 1 | 1998 | 11 | 0.170 |
Why?
|
| Candida albicans | 3 | 2014 | 32 | 0.170 |
Why?
|
| Male | 21 | 2020 | 40958 | 0.170 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 232 | 0.160 |
Why?
|
| Phenotype | 8 | 2022 | 2378 | 0.160 |
Why?
|
| Oligopeptides | 2 | 2016 | 179 | 0.160 |
Why?
|
| Cell Membrane Permeability | 3 | 2013 | 119 | 0.160 |
Why?
|
| Cell Line | 9 | 2017 | 2468 | 0.160 |
Why?
|
| Phenols | 2 | 2015 | 40 | 0.160 |
Why?
|
| Colonic Neoplasms | 1 | 2022 | 556 | 0.150 |
Why?
|
| Wound Infection | 1 | 2017 | 17 | 0.150 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 73 | 0.150 |
Why?
|
| Acinetobacter Infections | 1 | 2017 | 17 | 0.150 |
Why?
|
| Polymers | 2 | 2022 | 202 | 0.140 |
Why?
|
| Receptors, Purinergic P2X7 | 3 | 2000 | 9 | 0.140 |
Why?
|
| Operating Rooms | 1 | 2017 | 126 | 0.140 |
Why?
|
| Antihypertensive Agents | 1 | 2020 | 521 | 0.130 |
Why?
|
| Staphylococcal Infections | 1 | 2018 | 255 | 0.130 |
Why?
|
| Fascia | 1 | 2015 | 30 | 0.130 |
Why?
|
| Mutation | 4 | 2016 | 3967 | 0.130 |
Why?
|
| Oxygenases | 1 | 1995 | 13 | 0.130 |
Why?
|
| Drug Delivery Systems | 1 | 2016 | 178 | 0.130 |
Why?
|
| Nanoparticles | 1 | 2016 | 157 | 0.130 |
Why?
|
| Streptomyces | 1 | 1995 | 20 | 0.130 |
Why?
|
| Enzyme Inhibitors | 1 | 2018 | 639 | 0.130 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2016 | 153 | 0.130 |
Why?
|
| Opportunistic Infections | 2 | 2012 | 59 | 0.130 |
Why?
|
| Inflammation | 1 | 2020 | 920 | 0.130 |
Why?
|
| Dioxygenases | 1 | 1995 | 74 | 0.130 |
Why?
|
| Rats, Wistar | 4 | 2016 | 297 | 0.130 |
Why?
|
| Intraoperative Complications | 1 | 2016 | 185 | 0.130 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2016 | 109 | 0.120 |
Why?
|
| Thiazoles | 1 | 2015 | 131 | 0.120 |
Why?
|
| Negative Staining | 1 | 2014 | 2 | 0.120 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2014 | 29 | 0.120 |
Why?
|
| Cytostatic Agents | 1 | 2013 | 4 | 0.120 |
Why?
|
| Nicotine | 1 | 2016 | 194 | 0.120 |
Why?
|
| Models, Animal | 4 | 2019 | 263 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2009 | 1961 | 0.120 |
Why?
|
| Computer Simulation | 3 | 2013 | 1078 | 0.120 |
Why?
|
| Rats | 6 | 2020 | 3990 | 0.120 |
Why?
|
| Candidiasis | 1 | 2013 | 36 | 0.120 |
Why?
|
| Random Allocation | 4 | 2018 | 332 | 0.110 |
Why?
|
| Cell Cycle Proteins | 1 | 2016 | 388 | 0.110 |
Why?
|
| Obesity | 1 | 2019 | 963 | 0.110 |
Why?
|
| Ileum | 2 | 2012 | 159 | 0.110 |
Why?
|
| Organ Preservation | 1 | 2013 | 83 | 0.110 |
Why?
|
| Peritonitis | 1 | 2012 | 29 | 0.110 |
Why?
|
| Protein Transport | 1 | 2014 | 411 | 0.110 |
Why?
|
| Feces | 4 | 2020 | 319 | 0.110 |
Why?
|
| Oxidants | 1 | 2012 | 86 | 0.110 |
Why?
|
| Mast Cells | 3 | 2000 | 92 | 0.110 |
Why?
|
| Bacterial Infections | 1 | 2013 | 182 | 0.100 |
Why?
|
| Base Sequence | 3 | 2012 | 2330 | 0.100 |
Why?
|
| DNA Primers | 2 | 2006 | 543 | 0.100 |
Why?
|
| Drug Resistance, Bacterial | 3 | 2019 | 71 | 0.100 |
Why?
|
| Siderophores | 1 | 2011 | 22 | 0.100 |
Why?
|
| Bile Acids and Salts | 1 | 2011 | 61 | 0.100 |
Why?
|
| Hypoxia | 1 | 2016 | 641 | 0.100 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2012 | 78 | 0.100 |
Why?
|
| Urokinase-Type Plasminogen Activator | 2 | 2022 | 47 | 0.100 |
Why?
|
| Necrosis | 3 | 2012 | 204 | 0.100 |
Why?
|
| Cells, Cultured | 6 | 2013 | 2818 | 0.100 |
Why?
|
| Reperfusion Injury | 1 | 2011 | 131 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 1 | 2012 | 301 | 0.090 |
Why?
|
| Drug Design | 1 | 2011 | 124 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2002 | 381 | 0.090 |
Why?
|
| Wounds and Injuries | 1 | 2012 | 231 | 0.090 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2009 | 41 | 0.090 |
Why?
|
| Membrane Microdomains | 1 | 2009 | 54 | 0.090 |
Why?
|
| ErbB Receptors | 1 | 2012 | 485 | 0.090 |
Why?
|
| Radiation-Protective Agents | 1 | 2009 | 96 | 0.090 |
Why?
|
| Molecular Weight | 4 | 2013 | 332 | 0.090 |
Why?
|
| Ischemia | 3 | 2018 | 243 | 0.090 |
Why?
|
| Surgical Procedures, Operative | 2 | 2008 | 182 | 0.080 |
Why?
|
| Models, Biological | 2 | 2013 | 1749 | 0.080 |
Why?
|
| Interleukin-6 | 2 | 2020 | 256 | 0.080 |
Why?
|
| Leishmania | 1 | 2007 | 7 | 0.080 |
Why?
|
| Biomarkers | 3 | 2021 | 1718 | 0.080 |
Why?
|
| Longevity | 1 | 2008 | 51 | 0.080 |
Why?
|
| Rectus Abdominis | 2 | 2018 | 37 | 0.080 |
Why?
|
| 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 1 | 2007 | 10 | 0.080 |
Why?
|
| Software | 1 | 2011 | 654 | 0.080 |
Why?
|
| Adenylate Kinase | 3 | 2001 | 13 | 0.070 |
Why?
|
| Recombinant Proteins | 4 | 2015 | 1014 | 0.070 |
Why?
|
| DNA, Bacterial | 1 | 2008 | 236 | 0.070 |
Why?
|
| Cell Death | 4 | 2001 | 256 | 0.070 |
Why?
|
| DNA Fingerprinting | 1 | 2006 | 16 | 0.070 |
Why?
|
| Gentamicins | 1 | 2006 | 19 | 0.070 |
Why?
|
| Caspase 3 | 2 | 2011 | 159 | 0.070 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2006 | 36 | 0.070 |
Why?
|
| Bacterial Translocation | 3 | 2013 | 26 | 0.070 |
Why?
|
| Molecular Sequence Data | 4 | 2012 | 3030 | 0.070 |
Why?
|
| Endothelial Cells | 1 | 2008 | 428 | 0.070 |
Why?
|
| Disease Progression | 2 | 2020 | 1531 | 0.070 |
Why?
|
| Porins | 1 | 2005 | 21 | 0.070 |
Why?
|
| Actins | 1 | 2008 | 451 | 0.070 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2006 | 151 | 0.070 |
Why?
|
| Intensive Care Units | 3 | 2016 | 373 | 0.060 |
Why?
|
| Survival Analysis | 3 | 2013 | 1538 | 0.060 |
Why?
|
| Endotoxins | 1 | 2005 | 36 | 0.060 |
Why?
|
| Genome, Bacterial | 2 | 2020 | 139 | 0.060 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 2007 | 68 | 0.060 |
Why?
|
| Water | 1 | 2006 | 277 | 0.060 |
Why?
|
| Amino Acid Sequence | 3 | 2016 | 2062 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 927 | 0.060 |
Why?
|
| Movement | 1 | 2006 | 299 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 2357 | 0.060 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2000 | 315 | 0.060 |
Why?
|
| Adenosine | 1 | 2006 | 225 | 0.060 |
Why?
|
| Surface-Active Agents | 1 | 2004 | 59 | 0.060 |
Why?
|
| Cell Survival | 1 | 2006 | 969 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2006 | 2426 | 0.060 |
Why?
|
| Interferon-gamma | 1 | 2005 | 444 | 0.060 |
Why?
|
| Adenosine Diphosphate | 2 | 2000 | 55 | 0.060 |
Why?
|
| Administration, Oral | 2 | 2018 | 684 | 0.060 |
Why?
|
| Symbiosis | 1 | 2023 | 118 | 0.050 |
Why?
|
| Lung | 1 | 2008 | 1170 | 0.050 |
Why?
|
| Zonula Occludens-1 Protein | 2 | 2012 | 70 | 0.050 |
Why?
|
| Enema | 1 | 2021 | 37 | 0.050 |
Why?
|
| Taurocholic Acid | 1 | 2021 | 6 | 0.050 |
Why?
|
| Transcription, Genetic | 2 | 2020 | 1135 | 0.050 |
Why?
|
| Cloning, Molecular | 2 | 2003 | 646 | 0.050 |
Why?
|
| Critical Care | 1 | 2005 | 370 | 0.050 |
Why?
|
| Therapeutic Irrigation | 1 | 2021 | 60 | 0.050 |
Why?
|
| Energy Metabolism | 1 | 2003 | 271 | 0.050 |
Why?
|
| Cytochrome-c Peroxidase | 1 | 2000 | 2 | 0.050 |
Why?
|
| Microscopy, Confocal | 1 | 2021 | 268 | 0.050 |
Why?
|
| Proteomics | 2 | 2014 | 212 | 0.050 |
Why?
|
| Macrophages, Peritoneal | 1 | 2000 | 21 | 0.050 |
Why?
|
| Fatty Acids, Volatile | 1 | 2020 | 32 | 0.050 |
Why?
|
| Phagocytes | 1 | 2000 | 10 | 0.050 |
Why?
|
| Vibrio cholerae | 1 | 2000 | 17 | 0.050 |
Why?
|
| Burkholderia Infections | 1 | 2000 | 1 | 0.050 |
Why?
|
| Neoplasms | 1 | 2016 | 2898 | 0.050 |
Why?
|
| Butyric Acid | 1 | 2020 | 11 | 0.050 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2020 | 13 | 0.050 |
Why?
|
| Enzymes | 1 | 2000 | 47 | 0.050 |
Why?
|
| Protective Factors | 1 | 2019 | 22 | 0.050 |
Why?
|
| Mice, Inbred AKR | 1 | 1999 | 10 | 0.050 |
Why?
|
| Caseins | 1 | 1999 | 7 | 0.050 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2020 | 104 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 418 | 0.050 |
Why?
|
| Surface Properties | 1 | 2020 | 130 | 0.050 |
Why?
|
| Gastrectomy | 1 | 2020 | 68 | 0.050 |
Why?
|
| Particle Size | 1 | 2020 | 122 | 0.050 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2020 | 85 | 0.040 |
Why?
|
| Organic Chemicals | 1 | 2019 | 33 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2012 | 860 | 0.040 |
Why?
|
| Sodium Chloride | 1 | 1999 | 88 | 0.040 |
Why?
|
| Infliximab | 1 | 2020 | 151 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2003 | 416 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2019 | 121 | 0.040 |
Why?
|
| Antifibrinolytic Agents | 1 | 2019 | 30 | 0.040 |
Why?
|
| Time Factors | 3 | 2009 | 5209 | 0.040 |
Why?
|
| Proteolysis | 1 | 2019 | 100 | 0.040 |
Why?
|
| Serum Albumin, Bovine | 1 | 1999 | 45 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2015 | 1384 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2005 | 1195 | 0.040 |
Why?
|
| Colorimetry | 1 | 1998 | 8 | 0.040 |
Why?
|
| Cytochrome c Group | 3 | 2003 | 82 | 0.040 |
Why?
|
| Virus Replication | 1 | 2020 | 319 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 2 | 2011 | 425 | 0.040 |
Why?
|
| GTP Phosphohydrolases | 1 | 1999 | 71 | 0.040 |
Why?
|
| C-Reactive Protein | 1 | 2019 | 190 | 0.040 |
Why?
|
| Risk Factors | 2 | 2019 | 5417 | 0.040 |
Why?
|
| Tissue Engineering | 1 | 2020 | 181 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2011 | 493 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 1998 | 188 | 0.040 |
Why?
|
| CD24 Antigen | 1 | 2017 | 5 | 0.040 |
Why?
|
| Abscess | 1 | 2018 | 91 | 0.040 |
Why?
|
| Gelatinases | 1 | 2017 | 10 | 0.040 |
Why?
|
| Carcinogenesis | 1 | 2019 | 195 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2018 | 224 | 0.040 |
Why?
|
| Endoscopy | 1 | 2021 | 332 | 0.040 |
Why?
|
| Hyaluronan Receptors | 1 | 2017 | 36 | 0.040 |
Why?
|
| Culture Media | 1 | 2017 | 147 | 0.040 |
Why?
|
| Myocardium | 1 | 2020 | 529 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2020 | 482 | 0.040 |
Why?
|
| Cell Shape | 1 | 2017 | 51 | 0.040 |
Why?
|
| Abdominal Injuries | 1 | 2017 | 39 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 1313 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 2020 | 1074 | 0.040 |
Why?
|
| Serine Endopeptidases | 1 | 2017 | 145 | 0.040 |
Why?
|
| Moths | 1 | 2017 | 31 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2021 | 8477 | 0.040 |
Why?
|
| Neutrophils | 1 | 2018 | 307 | 0.040 |
Why?
|
| Comorbidity | 1 | 2020 | 943 | 0.040 |
Why?
|
| Recurrence | 1 | 2019 | 1139 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1019 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2020 | 510 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 864 | 0.030 |
Why?
|
| Electric Impedance | 2 | 2008 | 104 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2016 | 115 | 0.030 |
Why?
|
| Abdominal Muscles | 1 | 2015 | 19 | 0.030 |
Why?
|
| Fertility | 1 | 2016 | 115 | 0.030 |
Why?
|
| Cytokines | 2 | 2012 | 776 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2017 | 782 | 0.030 |
Why?
|
| Chlorophenols | 1 | 1995 | 1 | 0.030 |
Why?
|
| Azotobacter | 1 | 1995 | 3 | 0.030 |
Why?
|
| Sequence Analysis | 1 | 1995 | 26 | 0.030 |
Why?
|
| Metalloproteins | 1 | 1995 | 16 | 0.030 |
Why?
|
| Biodegradation, Environmental | 1 | 1995 | 17 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2015 | 96 | 0.030 |
Why?
|
| Genes, Reporter | 2 | 2006 | 268 | 0.030 |
Why?
|
| ras Proteins | 1 | 2016 | 128 | 0.030 |
Why?
|
| Drug Resistance, Fungal | 1 | 2014 | 8 | 0.030 |
Why?
|
| Staphylococcus | 1 | 2014 | 24 | 0.030 |
Why?
|
| Cell Hypoxia | 2 | 2006 | 164 | 0.030 |
Why?
|
| Enterobacteriaceae | 1 | 2014 | 21 | 0.030 |
Why?
|
| Cathartics | 1 | 2014 | 27 | 0.030 |
Why?
|
| Locomotion | 1 | 2016 | 131 | 0.030 |
Why?
|
| Homeostasis | 1 | 2016 | 409 | 0.030 |
Why?
|
| Enterococcus | 1 | 2014 | 35 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2016 | 199 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 1995 | 347 | 0.030 |
Why?
|
| Metagenomics | 1 | 2014 | 83 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2018 | 7990 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2013 | 77 | 0.030 |
Why?
|
| Cold Ischemia | 1 | 2013 | 17 | 0.030 |
Why?
|
| Mutagenesis, Insertional | 1 | 2013 | 111 | 0.030 |
Why?
|
| Organ Preservation Solutions | 1 | 2013 | 28 | 0.030 |
Why?
|
| Radiation | 1 | 2012 | 15 | 0.030 |
Why?
|
| Receptor Cross-Talk | 1 | 2012 | 33 | 0.030 |
Why?
|
| Cryopreservation | 1 | 2013 | 68 | 0.030 |
Why?
|
| Chloramines | 1 | 2012 | 20 | 0.030 |
Why?
|
| Tosyl Compounds | 1 | 2012 | 15 | 0.030 |
Why?
|
| Lactobacillus | 1 | 2012 | 21 | 0.030 |
Why?
|
| Calibration | 1 | 2012 | 99 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2012 | 74 | 0.030 |
Why?
|
| Protective Agents | 1 | 2012 | 33 | 0.030 |
Why?
|
| Acid Phosphatase | 1 | 2012 | 33 | 0.030 |
Why?
|
| Deoxycholic Acid | 1 | 2011 | 10 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 134 | 0.030 |
Why?
|
| Epithelium | 1 | 2013 | 319 | 0.030 |
Why?
|
| Oxidation-Reduction | 2 | 2003 | 373 | 0.030 |
Why?
|
| Protein Conformation | 1 | 1995 | 881 | 0.030 |
Why?
|
| Chemotaxis | 1 | 2012 | 72 | 0.030 |
Why?
|
| Benzhydryl Compounds | 1 | 2011 | 48 | 0.030 |
Why?
|
| Tight Junctions | 1 | 2012 | 149 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2013 | 989 | 0.020 |
Why?
|
| Fungal Proteins | 1 | 2012 | 141 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2002 | 2358 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 364 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2012 | 242 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 273 | 0.020 |
Why?
|
| Microclimate | 1 | 2010 | 4 | 0.020 |
Why?
|
| Reference Values | 1 | 2011 | 674 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2011 | 254 | 0.020 |
Why?
|
| Stem Cells | 1 | 2012 | 351 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 879 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 1034 | 0.020 |
Why?
|
| Microscopy, Video | 1 | 2008 | 34 | 0.020 |
Why?
|
| Color | 1 | 2009 | 81 | 0.020 |
Why?
|
| Cues | 1 | 2010 | 175 | 0.020 |
Why?
|
| Thrombin | 1 | 2008 | 61 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2008 | 137 | 0.020 |
Why?
|
| Adherens Junctions | 1 | 2008 | 34 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2012 | 853 | 0.020 |
Why?
|
| Acute Lung Injury | 1 | 2008 | 60 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 1920 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2008 | 129 | 0.020 |
Why?
|
| Cholesterol | 1 | 2009 | 356 | 0.020 |
Why?
|
| Protozoan Proteins | 1 | 2007 | 73 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 2008 | 193 | 0.020 |
Why?
|
| Inosine | 1 | 2006 | 19 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 1219 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2012 | 1578 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2012 | 1458 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2006 | 268 | 0.020 |
Why?
|
| Stomach | 1 | 2006 | 108 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2011 | 1196 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2006 | 179 | 0.020 |
Why?
|
| Parenteral Nutrition | 1 | 2005 | 60 | 0.020 |
Why?
|
| Genomics | 1 | 2010 | 720 | 0.020 |
Why?
|
| Transfection | 1 | 2006 | 896 | 0.020 |
Why?
|
| Aorta | 1 | 2006 | 280 | 0.020 |
Why?
|
| Toxicity Tests | 1 | 2003 | 13 | 0.010 |
Why?
|
| Caspase Inhibitors | 1 | 2003 | 33 | 0.010 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2003 | 53 | 0.010 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2003 | 75 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 2002 | 71 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2002 | 93 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2002 | 47 | 0.010 |
Why?
|
| Female | 3 | 2019 | 44509 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2005 | 712 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2005 | 728 | 0.010 |
Why?
|
| Cytosol | 1 | 2002 | 189 | 0.010 |
Why?
|
| Melanoma, Experimental | 1 | 2002 | 103 | 0.010 |
Why?
|
| Protein Binding | 1 | 2005 | 1456 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 189 | 0.010 |
Why?
|
| Adenine Nucleotides | 1 | 2001 | 63 | 0.010 |
Why?
|
| Catalysis | 1 | 2001 | 203 | 0.010 |
Why?
|
| Adult | 1 | 2020 | 25640 | 0.010 |
Why?
|
| 5'-Nucleotidase | 1 | 2000 | 13 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 1041 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2002 | 790 | 0.010 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2000 | 44 | 0.010 |
Why?
|
| Adenosine Monophosphate | 1 | 2000 | 27 | 0.010 |
Why?
|
| Proteins | 1 | 2006 | 777 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2002 | 579 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2002 | 480 | 0.010 |
Why?
|
| Kidney | 1 | 2006 | 1241 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2002 | 597 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 557 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 645 | 0.010 |
Why?
|
| Mitochondria | 1 | 2002 | 535 | 0.010 |
Why?
|
| Environment | 1 | 2000 | 219 | 0.010 |
Why?
|
| Melanoma | 1 | 2002 | 454 | 0.010 |
Why?
|